Hysteroscopic Findings With Histopathologic Report of Endometrium in Patients With Postmenopausal Bleeding
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Postmenopausal Bleeding. Basic parameters: from 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of Hysteroscopic Findings With Histopathologic Report of Endometrium in Patients With Postmenopausal Bleeding
Overview
To evaluate hysteroscopic findings in women with postmenopausal bleeding and correlate them with histopathological results of the endometrium., Sohag University Hospital Obstetrics and Gynecology department
Primary outcome measures
- evaluate hysteroscopic findings in women with postmenopausal bleeding and correlate them with histopathological results of the endometrium [Time frame: 2 weeks]
Eligibility criteria
Inclusion criteria
- Postmenopausal women presenting with uterine bleeding
- Age ≥ 45 years
\*Exclusion criteria:
- Women on hormone replacement therapy
- Bleeding due to vulvar, vaginal, cervical, or urethral causes
- Patients on anticoagulant therapy
- Patients unfit for hysteroscopy
- Refusal to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07707570 · Soh-Med-26-6-28MS